Rocket Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-5.5M | $-5.8M | $335.0K | $274.0K |
| FY2017 | $-16.0M | $-16.7M | $760.0K | $1.3M |
| FY2018 | $-53.8M | $-55.2M | $1.5M | $13.6M |
| FY2019 | $-64.7M | $-87.9M | $23.3M | $13.4M |
| FY2020 | $-74.6M | $-95.2M | $20.6M | $18.6M |
| FY2021 | $-121.2M | $-128.8M | $7.6M | $29.2M |
| FY2022 | $-178.1M | $-186.5M | $8.4M | $31.0M |
| FY2023 | $-194.9M | $-211.4M | $16.4M | $39.4M |
| FY2024 | $-209.7M | $-215.6M | $5.9M | $43.9M |
| FY2025 | $-190.0M | $-190.5M | $440.0K | $37.1M |